OPKO Health (OPK) – FDA
-
OPKO Health's (OPK) ModeX Presents Results from Phase 1 Study of ModeX Trispecific Antibody
-
Entera Bio (ENTX) and OPKO Biologics (OPK) Collaborate to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OPK Stock Lookup